Furthermore, accumulating evidence suggests that amyloid-related tau abnormalities progress more rapidly in APOE4 carriers, suggesting that APOE4 may facilitate earlier and more extensive amyloid-driven tau propagation across functionally connected brain regions [178]. The gene discussed is MAPT; the disease is amyloidosis.